investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Molecular Mechanism of Action of Phorbol Ester – Rockville
Peter Blumberg
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Better understand the biological role of RasGRP3; Better understand the biological function of PKC
Related projects
Byungkook Lee
Structural Bioinformatics
All cancers but non-melanoma skin cancer
Marc Nicklaus
Fundamentals of Ligand-Protein Interactions
All cancers but non-melanoma skin cancer
John Koren
Novel Combination Therapeutic Strategies to Ablate Resistance to Hsp90 Inhibitors
All cancers but non-melanoma skin cancer
Gobel Verena
Apical membrane modeling in tubulogenesis
All cancers but non-melanoma skin cancer
Vinay Pathak
Development of Novel Therapeutics by Targeting Vif-APOBEC3 Interactions
All cancers but non-melanoma skin cancer
David L Woodland
Stem Cells and Cancer
All cancers but non-melanoma skin cancer
Ira Pastan
Development of Improved Mesothelin Targeted Immunotoxins and other Tumor Specific Targeted Immunotoxins Using Proprietary Targeting Moieties
All cancers but non-melanoma skin cancer
Richard I. Gregory
Regulation of microRNA Biogenesis in Stem Cells
All cancers but non-melanoma skin cancer
Guillem Pratx
Quantitative Imaging of Cancer Drug Resistance via Radioluminescence Microarrays
All cancers but non-melanoma skin cancer
